| Literature DB >> 28837100 |
Armando Escobar-Ramos1, Carlos Ernesto Lobato-García2, Alejandro Zamilpa3, Abraham Gómez-Rivera4, Jaime Tortoriello5, Manasés González-Cortazar6.
Abstract
Haematoxylum campechianum is a medicinal plant employed as an astringent to purify the blood and to treat stomach problems such as diarrhea and dysentery. A bio-guided chemical fractionation of the methanolic extract obtained from this plant allowed for the isolation of five compounds: two chalcones known as sappanchalcone (1); 3-deoxysappanchalcone (2); three homoisoflavonoids known as hematoxylol A (3); 4-O-methylhematoxylol (4); and, hematoxin (5). The spasmolytic activity was determined in an in vitro model (electrically induced contractions of guinea pig ileum), and allowed to demonstrate that the methanolic extract (EC50 = 62.11 ± 3.23) fractions HcF7 (EC50 = 61.75 ± 3.55) and HcF9 (EC50 = 125.5 ± 10.65) and compounds 1 (EC50 = 16.06 ± 2.15) and 2 (EC50 = 25.37 ± 3.47) of Haematoxylum campechianum present significant relaxing activity as compared to papaverine (EC50 = 20.08 ± 2.0) as a positive control.Entities:
Keywords: Haematoxylum campechianum; chalcone; homoisoflavonoids; spasmolytic
Mesh:
Substances:
Year: 2017 PMID: 28837100 PMCID: PMC6151460 DOI: 10.3390/molecules22091405
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Concentration-response curves of the methanolic extract, HcF5 to HcF9 fractions of Haematoxilum campechianum induced contractions in isolated guinea pig ileum compared with papaverine as control (+).
Inhibitory effect of the methanolic extract, fractions (HcF5 to HcF9) and compounds (1–2, 3a–5a) of Haematoxilum campechianum induced contractions in isolated guinea pig ileum (Effective concentration fifty EC50, relaxation Emax).
| Extract, Fraction and Compounds | Effective Concentration Fifty (CE50 = µg/mL) | Relaxation (%) Emax |
|---|---|---|
| Extract MeOH | 62.11 ± 3.23 b | 85.16 ± 6.34 d |
| Fraction | ||
| HcF5 | 346.7± 19.32 f | 56.7 ± 1.8 c |
| HcF6 | 324.9 ± 10.15 f | 80.9 ± 2.5 d |
| HcF7 | 61.75 ± 3.55 b | 84.6 ± 1.7 d |
| HcF8 | 343.7 ± 10.04 f | 95.1 ± 1.2 e |
| HcF9 | 125.5 ± 10.65 c | 24.45 ±1.6 a |
| Compound | ||
| | 16.06 ± 2.15 a | 50.9 ± 2.2 b,c |
| | 25.37 ± 3.47 a | 48.5 ± 2.0 b |
| | 204.5 ± 2.75 d | 85.78 ± 2.7 d |
| | 285 ± 11.0 e | ND |
| | 203.1 ±7.2 d | 100 ±0.3 e |
| Papaverine (+) | 20.08 ± 2.0 a | 85.72 ± 2.8 d |
* Values are mean ± SD., n = 3 independent experiments performed in triplicates, and were determined by linear regression analysis using GraphPad Prism 6.0 Software; a–f Values are statistically significant at p < 0.05. ND = not determined.
Figure 2Inhibitory effect of compounds 1, 2 and 3a–5a, induced contractions in isolated guinea pig ileum, and compared with papaverine as a control (+).
13C-NMR data of homoisoflavonoids 1–5 (1 and 2 in CD3OD, 3a–5a in CDCl3, 150 MHz).
| Position | 1 | 2 | 3a | 4a | 5a |
|---|---|---|---|---|---|
| 2α | 124.8 | 125.2 | |||
| 3β | 144.2 | 144.2 | |||
| 1 C=O | 192.5 | 193.2 | |||
| 1′ | 121.8 | 121.8 | 134.3 | ||
| 2′ | 162.5 | 162.6 | 125.7 | ||
| 3′ | 99.8 | 100.3 | 141.6 | ||
| 4′ | 164.4 | 164.6 | 140.8 | ||
| 5′ | 108.7 | 109.0 | 122.9 | ||
| 6′ | 133.4 | 134.1 | 129.0 | ||
| 1 | 128.7 | 128.2 | 126.8 | 144.1 | |
| 2 | 114.9 | 131.5 | 120.6 | 69.4 | 130.1 |
| 3 | 146.8 | 117.0 | 136.5 | 69.9 | 180.4 |
| 4 | 149.6 | 161.3 | 132.7 | 76.2 | 136.6 |
| 4a | 149.2 | 118.2 | 160.7 | ||
| 5 | 116.2 | 117.0 | 128.5 | ||
| 6 | 123.0 | 131.5 | 76.9 | 113.9 | 77.5 |
| 7 | 55.87 | 56.28 | 203.6 | 143.6 | 70.0 |
| 8 | 49.0 | 130.9 | 38.67 | ||
| 8a | 142.0 | 146.6 | 133.9 | ||
| 9 | 125.2 | 38.2 | 123.3 | ||
| 10 | 142.1 | 56.2 | 141.8 | ||
| 11 | 144.3 | 167.7 | 140.6 | ||
| 12 | 125.0 | 168.2 | 121.7 | ||
| 12a | 136.3 | 130.0 | |||
| 12b | 131.0 | 52.7 | |||
| 13 | 167.9 | 168.4 | 83.75 | ||
| 14 | 168.5 | 168.4 | 62.51 | ||
| 15 | 168.6 | 20.64 | 168.0 | ||
| 16 | 168.7 | 20.65 | 168.0 | ||
| 17 | 20.80 | 20.3 | 20.52 | ||
| 18 | 21.23 | 20.3 | 20.68 | ||
| 19 | 21.16 | ||||
| 20 | 21.16 |
1H-NMR data of homoisoflavonoids 1–5 (1 and 2 in CD3OD, 3a–5a in CDCl3, 600 MHz, J in Hz).
| Position | 1 | 2 | 3a | 4a | 5a |
|---|---|---|---|---|---|
| 2α | 7.37, d, 15.7 | 7.40, d, 15.7 | |||
| 3β | 7.49, d, 15.7 | 7.55, d, 16.5 | |||
| 2′ | 7.18, s | ||||
| 3′ | 6.52, d, 2.2 | 6.51,d, 2.2 | |||
| 5′ | 6.46, dd, 2.2, 8.4 | 6.45, dd, 2.2, 8.4 | 7.14, d, 8.07 | ||
| 6′ | 7.57, d, 8.4 | 7.57, d, 8.4 | 7.21, d, 8.07 | ||
| 1 | 7.28, d, 8.4 | 7.08, d, 9.9 | |||
| 2α | 7.11, d, 2.2 | 7.49, dd, 1.8, 8.4 | 7.17, d, 8.8 | 3.94, d, 11.3 | 6.63, d, 10.2 |
| 2β | 4.19, d, 11.0 | ||||
| 3 | 6.81, dd, 1.8, 8.4 | ||||
| 4 | 3.7, s | ||||
| 5 | 6.79, d, 8.0 | 6.81, dd, 1.8, 8.4 | 7.02, d, 8.07 | ||
| 6α | 6.99, dd, 2.2, 8.0 | 7.49, dd, 1.8, 8.4 | 4.5, s | 6.72, d, 8.07 | 3.86, dd, 2.2, 11 |
| 6β | 4.21, d, 11 | ||||
| 7 | 3.9, s | 3.88, s | |||
| 8α | 3.6, s | 3.10, d, 16.5 | |||
| 8β | 3.40, d, 16.1 | ||||
| 9α | 7.2, s | 2.84, d, 13.5 | 7.03, s | ||
| 9β | 3.02, d, 14.3 | ||||
| 10 | 3.34 | ||||
| 12 | 7.18, s | 6.78, s | |||
| 13 | 3.6, s | ||||
| 14 | 3.6, s | ||||
| 15 | 2.3, s | ||||
| 16 | 2.3, s | ||||
| 17 | 2.35, s | 2.3, s | 2.24, s | ||
| 18 | 2.33, s | 2.3, s | 2.26, s | ||
| 19 | 2.3, s | ||||
| 20 | 2.3, s |
Figure 3HMBC correlations in compounds 1 and 2.